Frontiers in Oncology | Thoracic Oncology

Original Research

Published on 09 Oct 2020

Prognostic Value of the Lung Immune Prognostic Index May Differ in Patients Treated With Immune Checkpoint Inhibitor Monotherapy or Combined With Chemotherapy for Non-small Cell Lung Cancer

in Thoracic Oncology

Wenxian Wang
Zhangzhou Huang
Zongyang Yu
Wu Zhuang
Weijun Zheng
Zhijian Cai
Lei Shi
Xinmin Yu
Guangyuan Lou
Wei Hong

Frontiers in Oncology

doi 10.3389/fonc.2020.572853

4,620 views
23 citations

Review

Published on 09 Oct 2020

Neoadjuvant and Adjuvant Immunotherapy: Opening New Horizons for Patients With Early-Stage Non-small Cell Lung Cancer

in Thoracic Oncology

Rilan Bai
Lingyu Li
Xiao Chen
Naifei Chen
Wei Song
Jiuwei Cui

Frontiers in Oncology

doi 10.3389/fonc.2020.575472

16,566 views
52 citations

Original Research

Published on 30 Sep 2020

Clinical Outcomes for PD-1 Inhibitor Plus Chemotherapy as Second-Line or Later Therapy Compared to PD-1/PD-L1 Inhibitor Alone in Advanced Non-small-cell Lung Cancer

in Thoracic Oncology

Xiaoyang Zhai
Xuquan Jing
Ji Li
Yaru Tian
Shuhui Xu
Min Wang
Hui Zhu

Frontiers in Oncology

doi 10.3389/fonc.2020.556275

4,699 views
7 citations

Original Research

Published on 30 Sep 2020

Identification of Survival-Associated Alternative Splicing Signatures in Lung Squamous Cell Carcinoma

in Thoracic Oncology

Yang Liu
Wenxiao Jia
Ji Li
Hui Zhu
Jinming Yu

Frontiers in Oncology

doi 10.3389/fonc.2020.587343

4,804 views
15 citations

Perspective

Published on 30 Sep 2020

Harmonization of Molecular Testing for Non-Small Cell Lung Cancer: Emphasis on PD-L1

in Thoracic Oncology

Evgeny N. Imyanitov
Alexandr O. Ivantsov
Ilya V. Tsimafeyeu

Frontiers in Oncology

doi 10.3389/fonc.2020.549198

8,212 views
4 citations

Original Research

Published on 29 Sep 2020

Risk of Developing Checkpoint Immune Pneumonitis and Its Effect on Overall Survival in Non-small Cell Lung Cancer Patients Previously Treated With Radiotherapy

in Thoracic Oncology

Feliciano Barrón
Roberto Sánchez
Marisol Arroyo-Hernández
Carolina Blanco
Zyanya L. Zatarain-Barrón
Rodrigo Catalán
Maritza Ramos-Ramírez
Andrés F. Cardona
Diana Flores-Estrada
Oscar Arrieta

Frontiers in Oncology

doi 10.3389/fonc.2020.570233

5,965 views
35 citations

Original Research

Published on 25 Sep 2020

Combined Immunoscore for Prognostic Stratification of Early Stage Non-Small-Cell Lung Cancer

in Thoracic Oncology

Alice Boscolo
Francesco Fortarezza
Francesca Lunardi
Giovanni Comacchio
Loredana Urso
Stefano Frega
Jessica Menis
Laura Bonanno
Valentina Guarneri
Federico Rea

Frontiers in Oncology

doi 10.3389/fonc.2020.564915

3,825 views
8 citations

Review

Published on 25 Sep 2020

SABR-BRIDGE: Stereotactic ABlative Radiotherapy Before Resection to AvoId Delay for Early-Stage LunG Cancer or OligomEts During the COVID-19 Pandemic

in Thoracic Oncology

Biniam Kidane
Jonathan Spicer
Julian O. Kim
Pierre-Olivier Fiset
Bassam Abdulkarim
Richard Malthaner
David Palma

Frontiers in Oncology

doi 10.3389/fonc.2020.580189

9,488 views
20 citations

Perspective

Published on 25 Sep 2020

Telemedicine in Oncology: Delivering on an Overdue Promise in the COVID-19 Era

in Thoracic Oncology

Howard (Jack) West

Frontiers in Oncology

doi 10.3389/fonc.2020.578888

7,159 views
21 citations

Mini Review

Published on 24 Sep 2020

Microbiota and Lung Cancer. Opportunities and Challenges for Improving Immunotherapy Efficacy

in Thoracic Oncology

Maitane Ocáriz-Díez
Mara Cruellas
Marta Gascón
Rodrigo Lastra
Luis Martínez-Lostao
Ariel Ramírez-Labrada
José Ramón Paño
Andrea Sesma
Irene Torres
Alfonso Yubero

Frontiers in Oncology

doi 10.3389/fonc.2020.568939

8,680 views
23 citations

Original Research

Published on 24 Sep 2020

A Potential Biomarker of Combination of Tumor Mutation Burden and Copy Number Alteration for Efficacy of Immunotherapy in KRAS-Mutant Advanced Lung Adenocarcinoma

in Thoracic Oncology

Luochengling Xiang
Xiao Fu
Xiao Wang
Wenyuan Li
Xiaoqiang Zheng
Kejun Nan
Tao Tian

Frontiers in Oncology

doi 10.3389/fonc.2020.559896

4,468 views
16 citations

Review

Published on 23 Sep 2020

Exosome-Derived LncRNAs in Lung Cancer

in Thoracic Oncology

Tao Fan
Nan Sun
Jie He

Frontiers in Oncology

doi 10.3389/fonc.2020.01728

8,625 views
34 citations

Original Research

Published on 23 Sep 2020

Immune-Stromal Score Signature: Novel Prognostic Tool of the Tumor Microenvironment in Lung Adenocarcinoma

in Thoracic Oncology

Xiaoguang Qi
Chunyan Qi
Boyu Qin
Xindan Kang
Yi Hu
Weidong Han

Frontiers in Oncology

doi 10.3389/fonc.2020.541330

6,157 views
31 citations

Systematic Review

Published on 23 Sep 2020

Clinical Efficacy of Immune Checkpoint Inhibitors in Older Non-small-Cell Lung Cancer Patients: A Meta-Analysis

in Thoracic Oncology

You-Meng Sun
Ying Wang
Xin-Xing Sun
Jing Chen
Zhi-Ping Gong
Hai-Yan Meng

Frontiers in Oncology

doi 10.3389/fonc.2020.558454

3,848 views
18 citations

Review

Published on 23 Sep 2020

Therapeutic Landscape of Malignant Pleural Mesothelioma: Collateral Vulnerabilities and Evolutionary Dependencies in the Spotlight

in Thoracic Oncology

Duo Xu
Haitang Yang
Ralph A. Schmid
Ren-Wang Peng

Frontiers in Oncology

doi 10.3389/fonc.2020.579464

4,698 views
12 citations

Systematic Review

Published on 23 Sep 2020

Impact of Age on the Efficacy of Immune Checkpoint Inhibitor-Based Combination Therapy for Non-small-Cell Lung Cancer: A Systematic Review and Meta-Analysis

in Thoracic Oncology

Xin Yan
xuan tian
Zhiqiang Wu
Weidong Han

Frontiers in Oncology

doi 10.3389/fonc.2020.01671

5,825 views
41 citations